Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells.

Autor: Ilmer M; Current address: Department of General, Visceral and Transplantation Surgery, Hospital of the University of Munich (LMU), Munich, Germany., Mazurek N; Department of Gastroenterology, Hepatology and Nutrition, MD Anderson Cancer Center (MDACC), University of Texas Health Science Center at Houston, Houston, TX, USA., Gilcrease MZ; Department of Pathology, MD Anderson Cancer Center (MDACC), University of Texas Health Science Center at Houston, Houston, TX, USA., Byrd JC; Department of Gastroenterology, Hepatology and Nutrition, MD Anderson Cancer Center (MDACC), University of Texas Health Science Center at Houston, Houston, TX, USA., Woodward WA; Department of Breast Radiation Oncology, MD Anderson Cancer Center (MDACC), University of Texas Health Science Center at Houston, Houston, TX, USA., Buchholz TA; Department of Breast Radiation Oncology, MD Anderson Cancer Center (MDACC), University of Texas Health Science Center at Houston, Houston, TX, USA., Acklin K; Department of Stem Cell Transplantation and Cellular Therapies, MD Anderson Cancer Center (MDACC), University of Texas Health Science Center at Houston, Houston, TX, USA., Ramirez K; Department of Stem Cell Transplantation and Cellular Therapies, MD Anderson Cancer Center (MDACC), University of Texas Health Science Center at Houston, Houston, TX, USA., Hafley M; Department of Gastroenterology, Hepatology and Nutrition, MD Anderson Cancer Center (MDACC), University of Texas Health Science Center at Houston, Houston, TX, USA., Alt E; Department of Medicine, Tulane University Health Science Center, New Orleans, LA, USA., Vykoukal J; Department of Translational Molecular Pathology, MD Anderson Cancer Center (MDACC), University of Texas Health Science Center at Houston, Houston, TX, USA., Bresalier RS; Department of Gastroenterology, Hepatology and Nutrition, MD Anderson Cancer Center (MDACC), University of Texas Health Science Center at Houston, Houston, TX, USA. rbresali@mdanderson.org.

Publikováno v: Breast cancer research : BCR [Breast Cancer Res] 2016 Sep 29; Vol. 18 (1), pp. 97. Date of Electronic Publication: 2016 Sep 29.